1. Home
  2. UCL vs TIL Comparison

UCL vs TIL Comparison

Compare UCL & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

N/A

Current Price

$1.20

Market Cap

52.8M

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.25

Market Cap

54.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCL
TIL
Founded
2014
2018
Country
Hong Kong
United States
Employees
N/A
17
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.8M
54.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
UCL
TIL
Price
$1.20
$8.25
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
6.5K
21.2K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.60
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$5.67
52 Week High
$4.19
$42.75

Technical Indicators

Market Signals
Indicator
UCL
TIL
Relative Strength Index (RSI) 31.69 42.33
Support Level N/A $7.88
Resistance Level $1.41 $9.03
Average True Range (ATR) 0.07 0.54
MACD -0.00 -0.05
Stochastic Oscillator 0.00 29.71

Price Performance

Historical Comparison
UCL
TIL

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: